Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

November 5, 2019November 5, 2019

Inflammation in Airways of Sickle Cell Children Distinct from Asthma Alone, Pilot Study Suggests

News

White blood cells, especially monocytes, may underlie the breathing difficulties affecting children with sickle cell disease (SCD), a small pilot study suggests. Asthma is estimated to impact from 17% ... Read more

October 31, 2019October 31, 2019

NIH and Gates Foundation Each Invests $100M to Boost Development of Affordable Gene Therapies for Sickle Cell Disease, HIV

News

The National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation will each invest $100 million over the next four years to speed the development of affordable ... Read more

October 29, 2019October 29, 2019

Enhanced Parenting Skills May Help Improve Cognitive Function in SCD Children, Study Suggests

News

Enhanced parenting skills, including attentive listening and engaging in conversations, may help improve cognitive functioning in children with sickle cell disease (SCD), a study suggests. Parent stress was related ... Read more

October 24, 2019October 24, 2019

Caraphenol A May Facilitate Faster, More Effective Gene Therapies for Sickle Cell Anemia, Study Says

News

Caraphenol A — a small molecule closely related to a natural compound called resveratrol, which is produced by red grapes — increased the efficacy of hematopoietic stem cell-based gene ... Read more

October 8, 2019October 8, 2019

New Viral Vector May Make Gene Therapy for Sickle Cell More Effective, NIH Study Reports

News

A newly designed viral vector — the vehicle that delivers a gene therapy to a patient’s cells — for use in sickle cell anemia is more efficient than earlier vectors at ... Read more

September 19, 2019September 19, 2019

‘Sideline Sickle Cell’ Campaign Heads to Detroit to Raise Awareness about the Disease

News

A community town hall is set for Detroit to raise awareness about sickle cell disease, with a discussion about current and future therapies, as part of the Sideline Sickle ... Read more

September 17, 2019September 17, 2019

Hypertension Medication Valsartan May Help Prevent Vaso-Occlusive Episodes in Sickle Cell Disease, Study Suggests

News

A medication used to treat high blood pressure, called valsartan, may help decrease the stickiness of red blood cells and reduce the risk of vaso-occlusive crisis in people with ... Read more

August 20, 2019August 22, 2019

ICER Will Compare Lead Candidate Therapies Crizanlizumab and Voxelotor for Efficacy, Value

News

An upcoming analysis by the Institute for Clinical and Economic Review (ICER) will compare the clinical efficacy and economic value of Novartis’ crizanlizumab and Global Blood Therapeutics‘ voxelotor, lead ... Read more

August 13, 2019August 13, 2019

Cognitive Decline Not Evident in Black Americans with Sickle Cell Trait, Study Finds

News

African-Americans with sickle cell trait, carriers for sickle cell but without the disease, have no greater risk of cognitive decline than other adults of similar age, an analysis of a ... Read more

August 8, 2019August 8, 2019

Survival After Kidney Transplant Lower in SCD Patients Than Other Kidney Disease Patients, Analysis Shows

News

Survival of sickle cell disease patients (SCD) with end-stage renal disease who undergo kidney transplant is significantly lower compared to other renal disease patients who have the same procedure, ... Read more